• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Temodar (temozolomide) capsules and for injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2010


Summary View



Postmarketing Experience
  • Cases of interstitial pneumonitis/pneumonitis, alveolitis, and pulmonary fibrosis have been reported.